Fate Therapeutics Inc (NASDAQ:FATE)

4.98
Delayed Data
As of Feb 27
 +0.13 / +2.68%
Today’s Change
3.50
Today|||52-Week Range
13.55
-0.99%
Year-to-Date
No recent news for Fate Therapeutics Inc.

Today’s Trading

Previous close4.85
Today’s open5.09
Day’s range4.68 - 5.09
Volume7,600
Average volume (3 months)34,257
Market cap$102.4M
Dividend yield--
Data as of 3:59pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)-85.34%
Earnings growth (this year)+63.63%
Earnings growth (next 5 years)--
Revenue growth (last year)-63.63%
P/E ratio0.6
Price/Sales38.13
Price/Book2.00

Competitors

 Today’s
change
Today’s
% change
PIPPharmAthene Inc+0.06+3.70%
ORPNBio Blast Pharma Ltd-0.02-0.29%
CRMDCorMedix Inc-0.04-0.77%
ADMAADMA Biologics Inc-0.04-0.42%
Data as of 4:02pm ET, 02/27/2015

Financials

Next reporting dateMarch 16, 2015
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$971.0K
Annual profit (last year)-$20.9M
Net profit margin-2,151.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Christian Weyer
Chief Financial &
Operating Officer
J. Scott Wolchko
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account